ZNF41 activators exert their effects through a variety of cellular mechanisms, primarily by modulating intracellular signaling pathways that converge on the functional state of ZNF41. Some activators function by increasing the levels of intracellular second messengers such as cyclic AMP (cAMP), which can lead to the phosphorylation of ZNF41 through protein kinase A (PKA) or other cAMP-dependent pathways, thereby potentially enhancing its DNA-binding activity and functional capacity. This increase in cAMP is achieved by either direct activation of adenylate cyclase, inhibition of phosphodiesterases that degrade cAMP, or by providing cAMP analogs that mimic the action of endogenous cAMP, ensuring sustained activation of the signaling cascade that could positively influence ZNF41 activity.
Other mechanisms by which ZNF41 activity is increased involve the modulation of intracellular calcium levels. Certain activators are ionophores that facilitate the influx of calcium ions, potentially augmenting ZNF41 function if it is regulated by calcium-dependent signaling processes. Additionally, some compounds indirectly influence ZNF41 by activating protein kinase C, which may affect ZNF41 phosphorylation states and thus its DNA-binding affinity. Furthermore, certain activators might operate through pathways related to oxidative stress responses, contributing to the upregulation of ZNF41 activity in contexts where cellular redox states are perturbed, highlighting the diverse range of biochemical routes through which ZNF41 activity may be modulated.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Adenylate cyclase activator increasing cAMP levels, which could enhance the DNA-binding activity of ZNF41 by promoting its phosphorylation through PKA-dependent pathways. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $76.00 $265.00 | 80 | |
Calcium ionophore that raises intracellular calcium levels, potentially augmenting ZNF41 activity if ZNF41 is regulated by calcium-dependent signaling. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
Protein kinase C activator that might enhance ZNF41 function by modulating phosphorylation states that could affect its DNA-binding affinity. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $27.00 $37.00 | 5 | |
Beta-adrenergic agonist that increases cAMP levels, potentially facilitating the phosphorylation of ZNF41 through cAMP-dependent protein kinase pathways. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $159.00 $315.00 $598.00 | 34 | |
Non-specific phosphodiesterase inhibitor that prevents cAMP degradation, potentially sustaining ZNF41 activation through elevated cAMP levels. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $45.00 $130.00 $480.00 $4450.00 | 74 | |
cAMP analog that activates cAMP-dependent pathways, potentially promoting ZNF41 activity through phosphorylation by PKA. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $54.00 $128.00 $199.00 $311.00 | 23 | |
Calcium ionophore that increases intracellular calcium, possibly enhancing ZNF41 activity through calcium-sensitive pathways. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $42.00 $72.00 $124.00 $238.00 $520.00 $1234.00 | 11 | |
Antioxidant that may upregulate ZNF41 activity by affecting signaling pathways involved in oxidative stress responses. | ||||||
Zaprinast (M&B 22948) | 37762-06-4 | sc-201206 sc-201206A | 25 mg 100 mg | $103.00 $245.00 | 8 | |
Phosphodiesterase inhibitor that increases cAMP levels, which might further enhance ZNF41 activity via cAMP-dependent pathways. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $75.00 $212.00 | 18 | |
Phosphodiesterase-4 inhibitor that elevates cAMP levels, potentially promoting ZNF41 activation through cAMP-mediated signaling. | ||||||